Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes
Sponsor: University of Faisalabad
Summary
The aim of this clinical trial is to learn if omega-3 fatty acid supplements help maintain healthy blood vessels in the eyes of adults with type 1 diabetes. It will also learn about the safety of omega-3 supplements. The main questions it aims to answer are: Do omega-3 supplements improve the health of retinal blood vessels in adults with type 1 diabetes? Are there any side effects when taking omega-3 supplements? Researchers will compare participants taking omega-3 supplements to a control group (if applicable) to see if the supplements help support retinal blood vessel health. Participants will: Take a daily omega-3 supplement for the duration of the study Attend regular eye exams to monitor changes in the retina Report any side effects or health changes during the study
Official title: Role of Omega-3 Fatty Acids in Modulating Retinal Microvascular Changes in Type 1 Diabetes
Key Details
Gender
All
Age Range
10 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2025-10-01
Completion Date
2026-07-30
Last Updated
2025-12-01
Healthy Volunteers
No
Interventions
Omega 3 Fish Oil supplements
Arm 1 - Omega-3 Supplement Group: Intervention Type: Dietary Supplement Intervention Name: Omega-3 Fatty Acid Supplement Intervention Description: Participants will take one daily capsule containing 1000 mg of combined EPA and DHA. The supplement is taken orally with food. Eye exams will be performed every three months to monitor retinal blood vessel health. Participants will report any side effects such as mild stomach upset. Arm 2 - Placebo / Control Group: Intervention Type: Placebo Intervention Name: Placebo Capsule Intervention Description: Participants will take a daily capsule that looks identical to the omega-3 supplement but contains no active omega-3 fatty acids. Eye exams will be performed every three months to monitor retinal blood vessel health. Participants will report any health changes.
Locations (1)
Children Hospital Lahore and Ali Fatima Hospital
Lahore, Punjab Province, Pakistan